doxorubicin hydrochloride has been researched along with tariquidar in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, J; Ghaleb, H; Huang, W; Jiao, L; Kairuki, M; Liao, C; Lin, H; Pan, M; Qian, H; Zhou, J | 1 |
| Bi, X; Cui, J; Gao, Y; Huang, W; Li, Z; Liu, C; Qian, H; Shi, W; Wang, G | 1 |
| Cai, Z; Ghaleb, H; Huang, W; Jiang, Y; Liu, Y; Qian, H; Qiu, Q; Shi, W; Yin, Z; Zhang, P; Zhou, J; Zou, F | 1 |
3 other study(ies) available for doxorubicin hydrochloride and tariquidar
| Article | Year |
|---|---|
Synthesis and biological evaluation of JL-A7 derivatives as potent ABCB1 inhibitors.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; Carbon-13 Magnetic Resonance Spectroscopy; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Humans; Isoquinolines; Proton Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Triazoles | 2017 |
Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as P-glycoprotein-mediated multidrug resistance inhibitors.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Fluorescent Dyes; Humans; Isoquinolines; K562 Cells; Molecular Docking Simulation; Quinolines; Rhodamine 123; Structure-Activity Relationship | 2018 |
Exploration of novel phthalazinone derivatives as potential efflux transporter inhibitors for reversing multidrug resistance and improving the oral absorption of paclitaxel.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Neoplasm Proteins; Neoplasms; Paclitaxel | 2022 |